English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Small bowel evaluation has been considered for a long time technically challenging because of its length, location and tortuosity. But in 2001, with the FDA approval of capsule endoscopy started a revolution in the study of small bowel that, in the last years, has progressively and rapidly expanded [1-5]. Nevertheless, one of the main limitations to the spread of capsule endoscopy is the high cost and therefore a questionable cost-effectiveness when used in clinical practice. Lately the picture could change to the introduction in the European of a new video capsule system (OMOM CE) produced by Jinshan Science & Technology Company (Chongqing, China) [6, 7]; this device has and obtained the CE mark for marketing in Europe. Indeed, this device costs approximately half the other capsule systems. However, to date only few studies have been performed on the use in clinical practice of this new video capsule system, and none of them was carried out in the western world.

Feasibility, Safety and Diagnostic Yield of Omom Ce, a New Capsule Endoscopy System: The First Experience in Caucasian Patients